-
Comparative Effectiveness and Safety of Factor Xa Inhibitors in Atrial Fibrillation: A Systematic Literature Review of Real-World Evidence in Europe
Mar 10, 2025, 14:00 PM -
Avoidable Costs by the Inclusion Ff Finerenone in Terms of Hospitalization Due to Heart Failure (HF) and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Population-Based Risk Assessment and Hereditary Cancer Genetic Testing in Primary Care
Mar 10, 2025, 14:00 PM -
Racial Disparities in the Burden of Illness Among Adults with Prostate Cancer in the United States
Mar 10, 2025, 14:00 PM -
Evolving Real-world Trends in Biomarker Testing for Bladder Cancer: A Comprehensive Retrospective Analysis from the US Community Oncology Setting (2015-2024)
Mar 10, 2025, 14:00 PM -
Revolutionizing Multi-Level Network Meta-Regression: Advancing Analysis With the Package
Mar 10, 2025, 14:00 PM -
National Assessment of Breast and Cervical Cancer Screening Using National Health Interview Survey
Mar 10, 2025, 14:00 PM -
Pioneering the Integration of Health-Equity Variables Into an Administrative Claims Database: A Step Forward in the Journey to Supporting Underserved Populations
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Gabapentin, Pregabalin, and Duloxetine in the Treatment of Painful Diabetic Neuropathy: A Real-World Data-Based Net Benefit Regression Analysis
Mar 10, 2025, 14:00 PM -
Eosinophilic Esophagitis-Related Healthcare Resource Utilization and Associated Costs for Payers and Patients: A Retrospective Cohort Study of US Health Insurance Claims Data
Mar 10, 2025, 14:00 PM -
Glucocorticoid Exposure and the Risk of Serious Infections in CIDP
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review of Health Economic Models Structures for Chronic Rhinosinusitis with Nasal Polyps
Mar 10, 2025, 14:00 PM -
Assessing the Accuracy of Artificial Intelligence in Conducting Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Impacts of the Inflation Reduction Act on 2025 Formulary Coverage in Medicare Part D Plans
Mar 10, 2025, 14:00 PM -
Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Patients With C1 Inhibitor Deficiency (Type I/II) and =8 Attacks Per Month
Mar 10, 2025, 14:00 PM -
Exploratory Comparison of Medication Costs Among Non-Hodgkin Lymphoma Patients With and Without Z Code Documentation
Mar 10, 2025, 14:00 PM -
Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy for Treatment-Naive Patients of Extensive-Stage Small Cell Lung Cancer without Brain Metastasis
Mar 10, 2025, 14:00 PM -
Gender-Based Gaps In Access to Tricuspid Valve Interventions In England
Mar 10, 2025, 14:00 PM -
Health Technology Assessment in Saudi Arabia - Expectations for Oncology Product Eligibility Based on Predicate Canadian HTA
Mar 10, 2025, 14:00 PM
